EUVIMEDEUVIMED entdecken
Fallbericht

Amoxicillin-Clavulanate Dosing in the Intensive Care Unit: The Additive Effect of Renal Replacement Therapy in a Patient with Normal Kidney Function

Dagan Osborne Lonsdale, Jeffrey Lipman, Amelia Livermore, Brett McWhinney, Jacobus P J Ungerer, Jason A Roberts

Chemotherapy · 2019 · 64 (4) · 173-176

DOI: 10.1159/000505057 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Chemotherapy, online erschienen am 15.01.2020. Verfasst von Dagan Osborne Lonsdale und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pharmacy and Intensive Care, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia, daganlonsdale@gmail.com. Hauptthemen laut MEDLINE: Hemodiafiltration. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dosing of amoxicillin-clavulanic acid in critical illness is difficult as β-lactam pharmacokinetics are altered by physiological changes and therapies initiated in the intensive care unit such as renal replacement therapy (RRT). Successful treatment relies on sustaining a free antibiotic concentration above the minimum inhibitory concentration of the target pathogen (fT>MIC). We present a case of a patient treated with amoxicillin-clavulanic acid (1.2 g for 8 h) for an aspiration pneumonia. Dosing in this case was complicated by the necessity for RRT to treat a drug overdose with carbamazepine, despite normal native renal function. Antibiotic concentrations taken at steady state revealed a clearance of 14.6 L/h and a low fT>MIC (<40%). Analysis of the urine drug concentration suggested that 48% of clearance was via the native kidneys. This case illustrates that careful consideration of antibiotic dose and frequency is required in critically ill patients receiving RRT and highlights the need for further research in this patient group. In future similar cases, we would consider a dose of 2.2 g 6- or 8-hourly with early therapeutic drug monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemodiafiltrationAdultAlcohol DrinkingAmoxicillinChromatography, High Pressure LiquidClavulanic AcidHalf-LifeHumansIntensive Care UnitsKidneyKlebsiella pneumoniaeMaleMass SpectrometryPneumoniaPolypharmacySputumStaphylococcus aureus

Stichwörter der Autor:innen

AmoxicillinCritical careHaemodialysisPharmacokinetics

Substanzen

Clavulanic AcidAmoxicillin

Autor:innen und Institutionen

  • Departments of Pharmacy and Intensive Care, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia, daganlonsdale@gmail.com.
  • Departments of Pharmacy and Intensive Care, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.
  • Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France.
  • Department of Chemical Pathology, Pathology Queensland, Brisbane, Queensland, Australia.
  • Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Zitieren

APA

Lonsdale, D. O., Lipman, J., Livermore, A., McWhinney, B., Ungerer, J. P. J., & Roberts, J. A. (2019). Amoxicillin-Clavulanate Dosing in the Intensive Care Unit: The Additive Effect of Renal Replacement Therapy in a Patient with Normal Kidney Function. Chemotherapy, 64(4), 173-176. https://doi.org/10.1159/000505057

Vancouver

Lonsdale DO, Lipman J, Livermore A, McWhinney B, Ungerer JPJ, Roberts JA. Amoxicillin-Clavulanate Dosing in the Intensive Care Unit: The Additive Effect of Renal Replacement Therapy in a Patient with Normal Kidney Function. Chemotherapy. 2019;64(4):173-176. doi:10.1159/000505057

BibTeX
@article{Lonsdale2019,
  author = {Lonsdale, Dagan Osborne and Lipman, Jeffrey and Livermore, Amelia and McWhinney, Brett and Ungerer, Jacobus P J and Roberts, Jason A},
  title = {Amoxicillin-Clavulanate Dosing in the Intensive Care Unit: The Additive Effect of Renal Replacement Therapy in a Patient with Normal Kidney Function},
  journal = {Chemotherapy},
  year = {2019},
  volume = {64},
  number = {4},
  pages = {173--176},
  doi = {10.1159/000505057}
}
Kostenlos starten →